background
pneumonia
lead
caus
childhood
death
develop
world
higherqu
etiolog
data
requir
reduc
mortal
burden
method
conduct
casecontrol
studi
pneumonia
etiolog
among
children
age
month
rural
kenya
case
patient
hospit
world
health
organizationdefin
sever
pneumonia
sp
sever
pneumonia
vsp
control
outpati
children
without
pneumonia
collect
blood
cultur
induc
sputum
cultur
multiplex
polymeras
chain
reaction
pcr
obtain
oropharyng
swab
specimen
multiplex
pcr
case
patient
serum
serolog
nasopharyng
swab
specimen
multiplex
pcr
case
patient
control
result
elig
case
patient
enrol
studi
vsp
blood
cultur
posit
case
patient
predomin
potenti
pathogen
identifi
sputum
cultur
case
patient
respiratori
viru
detect
pcr
nasopharyng
swab
specimen
case
patient
control
respiratori
syncyti
viru
rsv
show
statist
signific
associ
viru
detect
nasopharynx
pneumonia
hospit
odd
ratio
confid
interv
among
case
patient
specimen
exclud
serum
specimen
collect
bacteria
identifi
virus
mix
viral
bacteri
infect
pathogen
bacteri
caus
outnumb
viral
caus
result
casecontrol
analysi
consid
conclus
potenti
etiolog
detect
children
admit
sp
vsp
except
rsv
casecontrol
analysi
detect
associ
viral
detect
nasopharynx
hospit
pneumonia
pneumonia
lead
caus
childhood
death
subsaharan
africa
anticip
particip
pneumonia
etiolog
research
child
health
perch
studi
comprehens
assess
etiolog
childhood
pneumonia
conduct
pilot
casecontrol
studi
method
determin
etiolog
among
infant
children
sever
pneumonia
admit
rural
kenyan
district
hospit
lesson
studi
appli
design
larger
multisit
perch
studi
studi
conduct
kilifi
district
rural
commun
kenyan
coast
malaria
endem
area
although
transmiss
declin
haemophilu
influenza
type
b
conjug
vaccin
introduc
coverag
dose
month
age
pneumococc
conjug
vaccin
introduc
time
studi
particip
children
age
month
case
patient
children
admit
kilifi
district
hospit
kdh
januarydecemb
sever
pneumonia
sp
sever
pneumonia
vsp
base
world
health
organ
definit
sp
defin
lower
chestwal
indraw
child
histori
cough
difficulti
breath
vsp
defin
cyanosi
oxygen
satur
inabl
feed
head
nod
impair
conscious
child
histori
cough
difficulti
breath
elig
base
clinic
data
admiss
control
conveni
sampl
children
attend
outpati
clinic
kdh
peripher
health
center
march
februari
meet
case
definit
sp
vsp
recruit
use
margin
frequenc
match
age
group
month
year
two
group
control
children
enrol
symptom
upper
respiratori
tract
infect
urti
includ
cough
runni
block
nose
sore
throat
without
symptom
sign
respiratori
infect
core
set
clinic
laboratori
investig
perform
case
patient
addit
investig
layer
onto
studi
gradual
clinic
laboratori
capac
increas
case
patient
investig
complet
blood
cell
count
blood
film
malaria
parasit
blood
cultur
infecti
serolog
nasopharyng
swab
np
oropharyng
swab
op
induc
sputum
sampl
analysi
urin
serum
assay
antimicrobi
activ
blood
cultur
process
use
bactec
instrument
bd
diagnost
h
influenza
serotyp
perform
slide
agglutin
follow
organ
consid
contamin
identifi
blood
cultur
bacillu
speci
coryneform
micrococcu
speci
coagulaseneg
staphylococci
viridan
streptococci
acut
serum
specimen
collect
enrol
followup
convalesc
specimen
collect
day
later
case
patient
control
analyz
presenc
immunoglobulin
g
antibodi
respiratori
syncyti
viru
rsv
influenza
influenza
b
parainfluenza
adenoviru
bordatella
pertussi
toxin
enzymelink
immunosorb
assay
euroimmun
pair
acuteconvalesc
serum
acut
nonpair
specimen
test
immunoglobulin
antibodi
mycoplasma
pneumonia
serodia
mycol
fujirebio
respiratori
pathogen
acut
infect
defin
increas
antibodi
titer
pair
acuteconvalesc
serum
specimen
pneumonia
singl
reciproc
titer
also
consid
posit
possibl
infect
b
pertussi
defin
singl
sampl
antibodi
concentr
miuml
hiv
test
perform
blood
case
patient
accord
kenyan
nation
polici
pediatr
hospit
admiss
use
rapid
antibodi
test
determin
inver
medic
innov
unigold
triniti
biotech
nasopharyng
flock
swab
specimen
copan
diagnost
collect
case
patient
control
case
patient
admit
januaryfebruari
junedecemb
oropharyng
polyurethan
foamtip
swab
sigmaswab
medic
wire
equip
collect
np
op
specimen
transport
describ
elsewher
swab
specimen
store
analyz
within
hour
collect
sputum
induc
hour
fast
sampl
obtain
jet
nebul
deliv
ml
steril
salin
minut
pretreat
nebul
salbutamol
prevent
bronchoconstrict
sputum
obtain
spontan
expector
suction
posterior
nasopharynx
steril
cathet
connect
specimen
trap
take
care
avoid
suction
anterior
nasal
content
specimen
collect
suction
cathet
flush
ml
steril
salin
evacu
residu
specimen
initi
specimen
collect
case
patient
suspect
tuberculosi
april
case
patient
underw
sputum
induct
specimen
investig
microscopi
bacteri
cultur
multiplex
polymeras
chain
reaction
pcr
clinic
indic
mycobacteri
cultur
assess
qualiti
sputum
specimen
use
bartlett
score
microscop
evalu
gram
stain
smear
number
squamou
epitheli
cell
per
lowpow
field
grade
cell
score
respect
presenc
leukocyt
leukocyt
score
respect
presenc
mucu
score
absenc
mucu
total
score
consid
indic
good
qualiti
isol
consid
potenti
caus
found
predomin
gram
stain
cultur
plate
organ
ziehlneelsen
stain
concentr
sputum
smear
examin
acidfast
bacilli
cultur
mycobacteria
use
bactec
migt
system
bd
diagnost
presenc
mycobacterium
tuberculosi
acidfast
bacilliposit
cultur
confirm
genotyp
mtbc
assay
hain
lifesci
nucleic
acid
extract
np
op
specimen
test
multiplex
pcr
respiratori
pathogen
rsv
b
adenoviru
rhinoviru
human
metapneumoviru
coronavirus
parainfluenza
virus
influenza
virus
b
c
pneumonia
detect
antimicrobi
activ
filter
paper
disk
inocul
serum
urin
place
nutrient
agar
plate
streak
staphylococcu
aureu
american
type
cultur
collect
incub
overnight
growth
inhibit
zone
extend
beyond
diamet
filter
paper
indic
antimicrobi
activ
analysi
perform
use
stata
softwar
version
statacorp
proport
compar
use
v
test
fisher
exact
test
continu
data
compar
test
agreement
pathogen
detect
multiplex
pcr
use
differ
specimen
type
assess
use
j
statist
estim
strength
associ
pathogen
detect
diseas
sever
odd
ratio
calcul
compar
case
patient
control
without
urti
multivari
logist
regress
adjust
age
group
month
season
dri
season
novemb
april
possibl
perform
logist
regress
cell
valu
fisher
exact
test
use
estim
signific
associ
etiolog
categor
bacteri
bacteri
pathogen
isol
blood
cultur
predomin
bacteri
pathogen
identifi
cultur
serum
specimen
posit
pneumonia
b
pertussi
pcr
result
posit
pneumonia
viral
np
op
specimen
pcr
result
posit
viral
pathogen
mix
bacterium
viru
identifi
unknown
anoth
model
etiolog
creat
includ
pathogen
significantli
associ
case
statu
casecontrol
analysi
studi
approv
kenya
nation
ethic
review
committe
oxford
tropic
ethic
review
committe
parent
guardian
particip
provid
written
inform
consent
among
children
age
month
admit
kdh
studi
period
met
case
definit
among
elig
consent
particip
studi
refus
approach
consent
die
admiss
process
consid
failur
computer
flag
system
approach
reason
elig
children
particip
significantli
older
higher
preval
malaria
parasitemia
higher
inpati
mortal
tabl
among
case
patient
sp
vsp
compar
sp
case
patient
vsp
longer
hospit
stay
higher
preval
malaria
parasitemia
higher
mortal
less
like
discharg
diagnosi
pneumonia
tabl
compar
control
case
patient
younger
averag
age
vs
month
control
p
higher
preval
midupperarm
circumfer
cm
vs
control
p
like
male
vs
control
p
blood
cultur
obtain
significantli
case
patient
sp
vsp
tabl
pathogen
identifi
contamin
blood
cultur
proport
case
patient
posit
blood
cultur
differ
sp
vsp
without
antimicrobi
activ
urin
serum
specimen
data
shown
among
patient
blood
cultur
hiv
test
perform
blood
cultur
posit
hivposit
case
patient
hivneg
case
patient
p
pathogen
isol
blood
cultur
streptococcu
pneumonia
n
nontyphi
salmonella
n
h
influenza
n
escherichia
coli
n
klebsiella
speci
n
group
streptococcu
n
aureu
n
burkholderia
speci
n
moraxella
catarrhali
n
campylobact
jejuni
n
two
h
influenza
isol
type
b
acut
convalesc
serum
specimen
collect
case
patient
control
case
patient
control
pair
serum
specimen
collect
similar
specimen
avail
term
age
sex
preval
midupperarm
circumfer
cm
hiv
infect
case
patient
pneumonia
sever
case
patient
data
shown
proport
case
patient
posit
serolog
assay
result
differ
case
patient
sp
vsp
pathogen
target
data
shown
serolog
test
identifi
infect
respiratori
pathogen
case
patient
control
tabl
serolog
test
provid
diagnosi
case
patient
test
neg
confirm
probabl
b
pertussi
infect
identifi
case
patient
month
age
month
age
vaccin
statu
unknown
casecontrol
analysi
suggest
associ
serolog
detect
rsv
admiss
sp
vsp
tabl
associ
serolog
evid
infect
pcr
detect
pathogen
specimen
type
pathogen
summar
supplementari
tabl
specimen
collect
case
patient
bartlett
score
tabl
b
among
case
patient
specimen
blood
cultur
blood
cultur
posit
children
posit
cultur
case
patient
pneumococc
bacteremia
pathogen
isol
cultur
pneumonia
n
catarrhali
n
pseudomona
aeruginosa
n
case
patient
klebsiella
pneumonia
bacteremia
h
influenza
cultur
sampl
case
patient
suspect
tuberculosi
cultur
posit
tuberculosi
base
clinic
find
highli
probabl
tuberculosi
diagnos
children
neg
cultur
respond
well
tuberculosi
treatment
respiratori
viru
detect
np
op
specimen
tabl
detect
np
specimen
patient
vsp
sp
p
parainfluenza
viru
detect
specimen
patient
vsp
sp
p
pneumonia
detect
specimen
patient
vsp
sp
p
signific
differ
patient
sp
vsp
specimenviru
combin
supplementari
tabl
ce
specimen
evalu
pcr
epitheli
cell
per
lowpow
field
ie
good
qualiti
evalu
viral
infect
specimen
qualiti
associ
pathogen
detect
supplementari
tabl
c
j
statist
compar
pcr
result
np
op
specimen
rang
influenza
c
rsv
tabl
respiratori
virus
detect
pcr
np
specimen
control
without
urti
virus
detect
urti
detect
except
rsv
viru
detect
associ
admiss
sp
vsp
tabl
classif
pneumonia
etiolog
vari
depend
specimen
algorithm
use
whether
casecontrol
result
taken
consider
figur
exampl
compar
first
second
row
figur
evid
cultur
increas
proport
case
patient
classifi
bacteri
pneumonia
inclus
multiplex
pcr
result
specimen
figur
row
shift
etiolog
classif
viral
predomin
inclus
multiplex
pcr
result
np
specimen
figur
row
among
case
patient
specimen
exclud
serum
specimen
collect
bacteria
identifi
virus
mix
viralbacteri
infect
pathogen
etiolog
unknown
case
patient
die
subset
figur
column
b
row
coinfect
detect
case
patient
specimen
exclud
serum
specimen
collect
coinfect
case
patient
among
virus
test
casecontrol
studi
provid
evid
pneumonia
etiolog
rsv
alon
take
consider
mean
rsv
viru
includ
etiolog
assess
etiolog
pneumonia
bacteri
viral
mix
unknown
figur
column
c
row
determin
etiolog
pediatr
pneumonia
challeng
given
difficulti
obtain
steril
cultur
site
infect
lack
diagnost
refer
standard
pilot
studi
potenti
pathogen
detect
hospit
children
age
month
clinic
signific
viral
pathogen
identifi
nucleic
acid
test
uncertain
given
high
preval
viral
detect
control
etiolog
fatal
pneumonia
remain
larg
unknown
diagnost
standpoint
ideal
specimen
sampl
diseas
tissu
lung
aspir
safe
obtain
children
pneumonia
provid
valuabl
diagnost
inform
howev
undertaken
studi
use
blood
cultur
alon
identifi
bacteri
caus
pneumonia
inadequ
poor
sensit
test
studi
explor
diagnost
util
collect
specimen
although
sputum
assess
criteria
rigor
evalu
children
vast
major
specimen
good
qualiti
accord
standard
criteria
use
conserv
definit
cultur
posit
potenti
bacteri
pathogen
identifi
cultur
twice
often
blood
cultur
pcr
specimen
identifi
potenti
viral
pathogen
half
case
patient
addit
refin
algorithm
interpret
result
may
requir
suggest
observ
find
blood
cultur
cultur
result
differ
case
patient
result
test
posit
find
similar
studi
pediatr
pneumonia
etiolog
use
pcr
previou
studi
patient
year
old
admit
kdh
use
multiplex
pcr
respiratori
virus
identifi
viru
np
specimen
sp
vsp
case
patient
rsv
domin
viru
found
specimen
use
multiplex
pcr
nasopharyng
aspir
specimen
viru
identifi
children
hospit
sp
mozambiqu
commonli
detect
virus
rhinoviru
adenoviru
rsv
studi
target
virus
nasopharyng
aspir
children
pneumonia
spain
suggest
viral
etiolog
use
combin
blood
sputum
cultur
pcr
immunoassay
nasopharyng
aspir
specimen
lahti
et
al
identifi
possibl
pathogen
children
age
month
year
hospit
pneumonia
finland
n
addit
pcr
target
increas
proport
posit
specimen
finnish
cohort
comprehens
pcr
analysi
virus
bacteria
identifi
potenti
pathogen
specimen
children
good
qualiti
sputum
specimen
virus
found
bacteria
use
sensit
nucleic
acid
detect
test
expand
abil
identifi
pathogen
children
pneumonia
howev
interpret
test
remain
challeng
background
colon
replic
persist
genet
materi
beyond
period
acut
infect
find
differ
match
casecontrol
studi
children
nepal
rsv
influenza
influenza
b
parainfluenza
human
metapneumoviru
associ
pneumonia
vari
degre
howev
nepal
studi
involv
outpati
nonsever
pneumonia
studi
hospit
children
pneumonia
rural
alaska
found
rhinoviru
adenoviru
coronavirus
detect
similar
proport
case
patient
outpati
control
rsv
human
metapneumoviru
parainfluenza
virus
influenza
virus
estim
caus
hospit
pneumonia
case
respect
studi
rsv
found
associ
hospit
pneumonia
similar
result
report
area
previous
analysi
present
figur
illustr
essenti
need
control
type
studi
assess
etiolog
shift
predominantli
viral
predominantli
bacteri
case
attribut
restrict
pathogen
associ
hospit
casecontrol
analysi
pathogen
small
effect
size
low
preval
larger
studi
need
assess
like
causat
quantifi
viral
genom
may
prove
use
link
detect
diseas
although
fairli
good
agreement
pcr
result
pair
np
op
specimen
agreement
upper
respiratori
tract
specimen
variabl
clinic
implic
find
unclear
lahti
et
al
report
good
agreement
pcr
detect
respiratori
virus
among
pair
nasopharyng
aspir
specimen
j
statist
one
could
hypothes
assay
perform
specimen
lower
respiratori
tract
would
specif
lower
respiratori
tract
infect
perch
investig
compar
viral
load
differ
type
specimen
serolog
test
indic
b
pertussi
might
import
caus
pneumonia
young
children
commun
abil
assess
correl
serolog
evid
infect
pcr
detect
respiratori
pathogen
limit
low
number
case
patient
complet
sampl
serolog
detect
case
adenoviru
pneumonia
none
detect
pcr
pcrdetect
case
adenoviru
parainfluenza
none
evid
serolog
test
poor
correl
may
relat
varieti
factor
includ
poor
immun
respons
certain
infect
young
children
inadequ
time
elaps
acut
convalesc
sampl
altern
may
reflect
nonspecif
pathogen
detect
upper
respiratori
tract
diagnost
marker
sp
vsp
could
explor
reassess
correl
use
result
quantit
pcr
final
perch
analysi
may
necessari
treat
serolog
test
diagnost
specif
highli
sensit
assay
half
elig
children
sp
vsp
die
hospit
stay
particip
studi
notabl
may
bia
etiolog
interpret
fatal
case
children
critic
understand
pneumonia
etiolog
take
concret
step
toward
reduc
mortal
wide
accept
guidelin
garner
inform
consent
parent
critic
ill
children
least
measur
need
ensur
investig
train
method
approach
individu
studi
sever
limit
stepwis
introduct
sampl
method
use
clinic
capac
specimen
collect
laboratori
capac
increas
assess
pneumonia
etiolog
shown
figur
taken
definit
studi
etiolog
kilifi
full
sampl
algorithm
implement
second
quarter
year
complet
sampl
avail
onethird
case
patient
inde
result
illustr
potenti
variabl
etiolog
depend
sampl
method
use
lung
aspir
postmortem
studi
perform
casecontrol
analysi
limit
comparison
result
np
specimen
serolog
test
could
assess
associ
pathogen
detect
nonsteril
site
specimen
pneumonia
hospit
collect
inform
durat
symptom
case
patient
control
possibl
high
preval
viral
detect
control
relat
ill
recent
past
among
case
patient
vsp
malaria
parasitemia
onethird
given
diagnosi
pneumonia
time
discharg
unexpect
given
world
health
organ
case
definit
deliber
nonspecif
order
sensit
hospit
set
specif
case
definit
sp
vsp
could
probabl
improv
use
chest
radiographi
compon
perch
studi
pilot
studi
illustr
ad
specimen
assay
sampl
algorithm
significantli
increas
detect
potenti
pathogen
impact
adjust
assess
etiolog
base
result
casecontrol
analysi
despit
fairli
comprehens
test
etiolog
pneumonia
remain
unknown
quarter
case
patient
diagnosi
may
pneumonia
other
extens
test
may
need
experi
find
pilot
studi
use
help
design
perch
studi
although
lung
aspir
postmortem
studi
perform
pilot
recogn
critic
better
understand
pneumonia
etiolog
fatal
pneumonia
children
perch
studi
incorpor
procedur
select
site
pilot
studi
found
collect
specimen
accept
parent
well
toler
feasibl
use
rural
develop
world
set
provid
use
diagnost
inform
specimen
collect
case
patient
without
contraind
although
infecti
serolog
test
use
decreas
frequenc
molecular
era
type
test
provid
etiolog
inform
may
help
interpret
associ
detect
pathogen
urt
pneumonia
necessari
home
visit
conduct
increas
collect
convalesc
serum
specimen
commun
accept
recruit
sampl
control
perch
specimen
control
expand
includ
op
blood
urin
specimen
addit
np
specimen
maxim
abil
detect
associ
pathogen
detect
hospit
pneumonia
use
comprehens
approach
perch
studi
wellposit
provid
definit
inform
etiolog
sp
vsp
children
develop
world
supplementari
materi
avail
clinic
infecti
diseas
onlin
http
cidoxfordjournalsorg
supplementari
materi
consist
data
provid
author
publish
benefit
reader
post
materi
copyedit
content
supplementari
data
sole
respons
author
question
messag
regard
error
address
author
